Tulane Ventures

Informuta, Inc. is a startup developing a predictive diagnostic platform that uses machine learning to assess bacterial infections for antibiotic resistance and predict the likelihood of future resistance, based on research identifying a genetic "mutational signature" in bacteria like Pseudomonas aeruginosa. The company was founded by Tulane University researchers and aims to address antibiotic resistance and reduce antibiotic misuse in clinical practice.